A new technical paper, “Neural Computers,” was published by researchers at Meta AI and KAUST. Abstract “We propose a new ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Cancer biology research increasingly recognizes the profound heterogeneity and plasticity of cancer cells. These cells can transition dynamically between ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...

iACT Stealth is designed to work in tandem with Pluristyx's FailSafe (R) technology. FailSafe's drug-inducible safety feature acts as a genetic "kill switch," allowing for the selective removal of any ...

The FDA granted regenerative medicine advanced therapy designation to RTx-015 for the treatment of retinitis pigmentosa.